| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/30/2006 | CN1823947A Naodesheng preparation and its new preparation method |
| 08/30/2006 | CN1823944A Heart beneficial keton dispersion tablet and its preparation method |
| 08/30/2006 | CN1823943A Preparation technology of Chinese medicine naodesheng concentrate pill |
| 08/30/2006 | CN1823922A Medicinal composition containing borneol |
| 08/30/2006 | CN1823916A Extraction method of polygala refined total saponin |
| 08/30/2006 | CN1823915A Medicine for treating coronary heart disease |
| 08/30/2006 | CN1823909A Ultrasonic extraction technology of xiasangju |
| 08/30/2006 | CN1823908A New technology for refining xiasanju extract using membrane separation technique |
| 08/30/2006 | CN1823899A Quality control method for dandengtongnao oral preparation |
| 08/30/2006 | CN1823898A Compound shuangshenxinshu prepared Chinese medicine and its preparation method and application in treating coronary heart disease |
| 08/30/2006 | CN1823896A Nutritire product for preventing and treating cardiac and cerebral vascular system disease |
| 08/30/2006 | CN1823890A Formula of oral Chinese medicine used for treating virus myocarditis |
| 08/30/2006 | CN1823876A Persimmon leaf extract controlled slow-release preparation and its preparation method |
| 08/30/2006 | CN1823875A Medicinal composition of trichosanthes rind and its preparation method |
| 08/30/2006 | CN1823872A Biological preparation capable of improving cardio cerebral function |
| 08/30/2006 | CN1823856A Method of extracting polyphenol from pomegranate seed |
| 08/30/2006 | CN1823853A Ginkgodamo drip pill and its preparation method |
| 08/30/2006 | CN1823852A Quality control method of ginkgo oral carity disintegration tablet |
| 08/30/2006 | CN1823844A Artificial musk oral disintegration tablet for preventing and fast first aid stenocardia and its preparation method |
| 08/30/2006 | CN1823815A Application of sodium sulfide vein injection liquid in preparation of medicine for treating sequela of cerebral embolism death |
| 08/30/2006 | CN1823807A Micronize diosmin and hesperidine composition suppository |
| 08/30/2006 | CN1823803A Erigeron breviscapus injection preparation and its preparation method |
| 08/30/2006 | CN1823801A Application of peracetyl pueraria in preparation of medicine for treating blood deficient cerebrovascular disease |
| 08/30/2006 | CN1823799A Erigeron breviscapus slow release agent and its preparation method |
| 08/30/2006 | CN1823798A Application of isobaicalin in preparation of medicine |
| 08/30/2006 | CN1823792A New liver beneficial capsule and its preparation method |
| 08/30/2006 | CN1823786A Sterilization technology of prostadil fatty emulsion and method of determination |
| 08/30/2006 | CN1823784A Herbeishatan hydrochlorothiazine dispersion tablet |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823778A Medicinal composition used for treating cardiovascular cerebrovascular disease and its preparation method |
| 08/30/2006 | CN1823777A Nicergoline soft capsule and its preparation method |
| 08/30/2006 | CN1823776A Vinpocetine solid liposome nano-particle and its preparation technology |
| 08/30/2006 | CN1823767A Medicinal composition for treating cerebrovascular disease |
| 08/30/2006 | CN1823765A Indapamide percutaneous controlled releast plaster and its preparation method |
| 08/30/2006 | CN1823762A Chuanxiong lactone kind component soft capsule for treating cardiovascular and cerebrovascular diseases |
| 08/30/2006 | CN1823759A Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823748A Medicinal preparation of coenzyme Q10 liposome and its preparation technology |
| 08/30/2006 | CN1823729A Butyl benzene phthalein vein emulsion and its application |
| 08/30/2006 | CN1823604A Seaweed tea and its preparation method |
| 08/30/2006 | CN1272331C Method of extracting three effective components in kudzu vine root |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272326C Phenylpyridazine derivatives and drugs containing the same |
| 08/30/2006 | CN1272319C Process for making amlodipine maleate |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272064C Prescription for treating cardiovascular disease and processing method |
| 08/30/2006 | CN1272060C Medicine for preventing apoplexy and its preparation method |
| 08/30/2006 | CN1272045C Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 08/30/2006 | CN1272039C Chinese patent medicine for treating apoplexy and its preparation method |
| 08/30/2006 | CN1272037C Freeze-dried powder injection for treating carido-cerebrovascular disease and preparing method thereof |
| 08/30/2006 | CN1272036C Medicinal injection for treating cardio-cerebrovascular disease and preparing method thereof |
| 08/30/2006 | CN1272026C Medicinal composition for treating cardiocerebral vasculr disease and its preparing method |
| 08/30/2006 | CN1272021C Internal hemorrhoid injection |
| 08/30/2006 | CN1272013C Use of bisphosphonates in preparing drugs for treating diseases with abnormal bone formation in bone remodeling |
| 08/30/2006 | CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 08/30/2006 | CN1271995C Orally disintegrating tablet of 'Xintongning' and its preparation |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098336 FXR NR1H4 nuclear receptor binding compounds |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098246 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098233 5-halo-tryptamine derivatives used as ligands on the 5-HT6 and/or 5-HT7 serotonin receptors |
| 08/29/2006 | US7098220 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097833 Increasing blood flow to regenerate and prevent cardiac failure in tissue experiencing ischemic events; neovasculaization; tissue engineering |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/29/2006 | CA2342390C Sustained release ranolazine formulations |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/24/2006 | WO2006088748A2 Method for treating obesity |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088080A1 CYCLOHEPTA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006087420A2 A method for treating heart failure |
| 08/24/2006 | WO2006087419A2 A method for administering levosimendan |
| 08/24/2006 | WO2006087371A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/24/2006 | WO2006087117A1 Therapeutic combinations of manidi pine and a statin |
| 08/24/2006 | WO2006086921A1 A process for the preparation of clopidogrel |
| 08/24/2006 | WO2006072888A3 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 08/24/2006 | WO2006071802A3 Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
| 08/24/2006 | WO2006043858A3 Method for cleaning the internal environment of an organism and endoecological correction agent |
| 08/24/2006 | WO2006009464A3 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189671 Compounds, compositions, and methods |
| 08/24/2006 | US20060189669 Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy |
| 08/24/2006 | US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |